Patient Registry Software Market Size, Share, Opportunities, And Trends By Registry Type (Disease Registry, Health Service Registry, Product Registry), By Software Type (Stand-alone Software, Integrated Software), By Functionality (Population Health Management, Health Information Exchange, Patient Care Management, Medical Research and Clinical Studies, Others), By End-User (Hospital, Government Organizations and Third-Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, Others), And By Geography - Forecasts From 2024 To 2029

The patient registry software market is witnessing notable growth as healthcare systems increasingly embrace digital solutions for efficient data management and analysis. Patient registry software plays a pivotal role in aggregating, organizing, and analyzing patient data to facilitate comprehensive healthcare research, monitor disease trends, and enhance patient outcomes. This software streamlines the collection of real-world patient information, allowing healthcare professionals and researchers to gain insights into various conditions and treatment outcomes. With a focus on improving healthcare quality and advancing medical research, patient registry software enables healthcare organizations to efficiently manage patient information, track disease progression, and contribute valuable data to clinical studies. As the healthcare industry continues to prioritize data-driven insights, the patient registry software market is positioned for continued expansion to meet the evolving needs of modern healthcare.

Market Drivers

• Rising patient registries

The anticipated patient registry software market growth is fueled by global initiatives launching new patient registries and the implementation of key strategies, such as mergers and acquisitions, throughout the study period. A notable example is the April 2022 introduction of a registry by Cerner, designed to accumulate data from individuals diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disorder. This registry aims to gather both retrospective and prospective clinical and health outcome data for Gaucher disease patients, with a specific focus on expediting the discovery, development, and delivery of insights and therapies to enhance overall health outcomes. This proactive approach reflects the industry's commitment to leveraging patient registry software for comprehensive data collection and analysis, ultimately advancing healthcare research and improving patient care.

• Increasing market collaborations

The patient registry market expansion is anticipated to be further propelled by the introduction of new products in the segment. A noteworthy example is the collaboration between UC San Francisco (UCSF), the Quantum Leap Healthcare Collaborative (QLHC), and the United States Food and Drug Administration (FDA), leading to the development of the OneSource system in April 2022. This electronic data capture (EDC) system is designed to seamlessly integrate clinical care and research data, revolutionizing the collection and distribution of patient health data for clinical trials. The engagement in such partnerships and collaborations by key industry players is expected to diversify their product portfolios and significantly contribute to the overall market growth.

North America is anticipated to hold a significant share of the market-

The North American region is poised to experience substantial growth during the study period, driven by factors such as the increasing uptake of electronic health records, government initiatives promoting the adoption of patient registry software, and a surge in research and development activities undertaken by pharmaceutical companies. Within North America, the United States is anticipated to lead the market. The United States has been at the forefront of digital infrastructure development for healthcare, with the early adoption of electronic health records. An article published in January 2022, titled "How A Clinical Data Registry Can Work With Your EHR," highlights the use of data registries to assist clinicians in selecting the most effective treatment for patients with similar diseases or conditions. It also enables real-time analysis of trends in the patient population, such as evaluating the effectiveness of new therapies compared to existing treatments. Consequently, the perceived advantages of patient registries are expected to drive their increased adoption in the United States, contributing to the market growth in the region.

Market Developments

• In January 2023, Seqster collaborated with the National Pancreas Foundation (NPF) to establish the largest dynamic database for pancreatic patient diseases in the nation. This database has the potential to expedite cutting-edge research more efficiently than conventional methods.
• In May 2022, the National Pancreas Foundation (NPF) initiated the pancreatic disease patient registry in collaboration with SeqsterOS. This patient-focused registry empowers patients and their caregivers to construct their longitudinal patient records, incorporating real-time data sourced from electronic health records (EHR), genomic DNA tests, and wearable/remote monitoring devices.
• In April 2022, Quantori, LLC introduced a Registry Science Practice with a primary focus on developing registry programs tailored for patients, clinicians, and researchers.
• In March 2022, the Rare Diseases Clinical Research Network (RDCRN) unveiled a contact registry designed to establish connections between rare disease patients and researchers, fostering advancements in rare disease research. This registry is dedicated to compiling and managing the contact details of individuals interested in receiving information about rare disease research. Moreover, it will keep participants informed about potential opportunities to engage in research initiatives.

Market Segmentation

• By Registry Type
  • Disease Registry
  • Health Service Registry
  • Product Registry
• By Software Type
  • Stand-alone Software
  • Integrated Software
• By Functionality
  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others
• By End-User
  • Hospital
  • Government Organizations and Third-Party Administrators (TPAs)
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. PATIENT REGISTRY SOFTWARE MARKET BY REGISTRY TYPE

5.1. Introduction

5.2. Disease Registry

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Cardiovascular Registry

5.2.4. Diabetes Registry

5.2.5. Cancer Registry

5.2.6. Rare Disease Registry

5.2.7. Others

5.3. Health Service Registry

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.4. Product Registry

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.4.3. Medical Device Registry

5.4.4. Drug Registry

6. PATIENT REGISTRY SOFTWARE MARKET BY SOFTWARE TYPE

6.1. Introduction

6.2. Stand-alone Software

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Integrated Software

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

7. PATIENT REGISTRY SOFTWARE MARKET BY FUNCTIONALITY

7.1. Introduction

7.2. Population Health Management

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Health Information Exchange

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

7.4. Patient Care Management

7.4.1. Market Trends and Opportunities

7.4.2. Growth Prospects

7.5. Medical Research and Clinical Studies

7.5.1. Market Trends and Opportunities

7.5.2. Growth Prospects

7.6. Others

7.6.1. Market Trends and Opportunities

7.6.2. Growth Prospects

8. PATIENT REGISTRY SOFTWARE MARKET BY END-USER

8.1. Introduction

8.2. Hospitals

8.2.1. Market Trends and Opportunities

8.2.2. Growth Prospects

8.3. Government Organizations and Third-Party Administrators (TPAs)

8.3.1. Market Trends and Opportunities

8.3.2. Growth Prospects

8.4. Pharmaceutical, Biotechnology, and Medical Device Companies

8.4.1. Market Trends and Opportunities

8.4.2. Growth Prospects

8.5. Other 

8.5.1. Market Trends and Opportunities

8.5.2. Growth Prospects

9. PATIENT REGISTRY SOFTWARE MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Registry Type

9.2.2. By Software Type

9.2.3. By Functionality

9.2.4. By End-User

9.2.5. By Country

9.2.5.1. United States

9.2.5.1.1. Market Trends and Opportunities

9.2.5.1.2. Growth Prospects

9.2.5.2. Canada

9.2.5.2.1. Market Trends and Opportunities

9.2.5.2.2. Growth Prospects

9.2.5.3. Mexico

9.2.5.3.1. Market Trends and Opportunities

9.2.5.3.2. Growth Prospects

9.3. South America

9.3.1. By Registry Type

9.3.2. By Software Type

9.3.3. By Functionality

9.3.4. By End-User

9.3.5. By Country 

9.3.5.1. Brazil

9.3.5.1.1. Market Trends and Opportunities

9.3.5.1.2. Growth Prospects

9.3.5.2. Argentina

9.3.5.2.1. Market Trends and Opportunities

9.3.5.2.2. Growth Prospects

9.3.5.3. Others

9.3.5.3.1. Market Trends and Opportunities

9.3.5.3.2. Growth Prospects

9.4. Europe

9.4.1. By Registry Type

9.4.2. By Software Type

9.4.3. By Functionality

9.4.4. By End-User

9.4.5. By Country

9.4.5.1. United Kingdom

9.4.5.1.1. Market Trends and Opportunities

9.4.5.1.2. Growth Prospects

9.4.5.2. Germany

9.4.5.2.1. Market Trends and Opportunities

9.4.5.2.2. Growth Prospects

9.4.5.3. France

9.4.5.3.1. Market Trends and Opportunities

9.4.5.3.2. Growth Prospects

9.4.5.4. Italy

9.4.5.4.1. Market Trends and Opportunities

9.4.5.4.2. Growth Prospects

9.4.5.5. Spain

9.4.5.5.1. Market Trends and Opportunities

9.4.5.5.2. Growth Prospects

9.4.5.6. Others

9.4.5.6.1. Market Trends and Opportunities

9.4.5.6.2. Growth Prospects

9.5. Middle East and Africa

9.5.1. By Registry Type

9.5.2. By Software Type

9.5.3. By Functionality

9.5.4. By End-User

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.1.1. Market Trends and Opportunities

9.5.5.1.2. Growth Prospects

9.5.5.2. UAE

9.5.5.2.1. Market Trends and Opportunities

9.5.5.2.2. Growth Prospects

9.5.5.3. Others

9.5.5.3.1. Market Trends and Opportunities

9.5.5.3.2. Growth Prospects

9.6. Asia Pacific

9.6.1. By Registry Type

9.6.2. By Software Type

9.6.3. By Functionality

9.6.4. By End-User

9.6.5. By Country

9.6.5.1. Japan

9.6.5.1.1. Market Trends and Opportunities

9.6.5.1.2. Growth Prospects

9.6.5.2. China

9.6.5.2.1. Market Trends and Opportunities

9.6.5.2.2. Growth Prospects

9.6.5.3. India

9.6.5.3.1. Market Trends and Opportunities

9.6.5.3.2. Growth Prospects

9.6.5.4. South Korea

9.6.5.4.1. Market Trends and Opportunities

9.6.5.4.2. Growth Prospects

9.6.5.5. Taiwan

9.6.5.5.1. Market Trends and Opportunities

9.6.5.5.2. Growth Prospects

9.6.5.6. Thailand

9.6.5.6.1. Market Trends and Opportunities

9.6.5.6.2. Growth Prospects

9.6.5.7. Indonesia

9.6.5.7.1. Market Trends and Opportunities

9.6.5.7.2. Growth Prospects

9.6.5.8. Others

9.6.5.8.1. Market Trends and Opportunities

9.6.5.8.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Dacima Software Inc.

11.2. FIGmd Inc.

11.3. Global Vision Technologies Inc.

11.4. Image Trend Inc.

11.5. IQVIA

11.6. Ordinal Data, Inc.

11.7. McKensson Corporation

11.8. Syneos Health

11.9. Cerner Corporation

11.10. IBM

11.11. ArborMetrix 

Dacima Software Inc.

FIGmd Inc.

Global Vision Technologies Inc.

Image Trend Inc.

IQVIA

Ordinal Data, Inc.

McKensson Corporation

Syneos Health

Cerner Corporation

IBM

 

ArborMetrix